IDiyas

For the Inventor, By the Inventor

Netanya, Israel

Tamas Koltai

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Petah Tiqva, IL (2006 - 2010)
  • Natanja, IL (2008 - 2010)
  • Netanya, IL (2008 - 2013)
  • Natanya, IL (2012 - 2013)

Company Filing History:

goldMedal15 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 2006-2013

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8614252 - Crystalline solid rasagiline base (2013-12-24),
2. 8592442 - Nilotinib HCl crystalline forms (2013-11-26),
3. 8227477 - Nilotinib HCl crystalline forms (2012-07-24),
4. 8207361 - Tigecycline crystalline forms and processes for preparation thereof (2012-06-26),
5. 7871993 - Tigecycline crystalline forms and processes for preparation thereof (2011-01-18),
6. 7855233 - Citrate salt of Rasagiline (2010-12-21),
7. 7842717 - DNT-maleate and methods of preparation thereof (2010-11-30),
8. 7750051 - Crystalline solid rasagiline base (2010-07-06),
9. 7692023 - Candesartan cilexetil polymorphs (2010-04-06),
10. 7687642 - Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them (2010-03-30),
11. 7678799 - Crystalline ziprasidone HCl and processes for preparation thereof (2010-03-16),
12. 7547806 - Tannate salt of rasagiline (2009-06-16),
13. 7414140 - Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them (2008-08-19),
14. 7399871 - Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof (2008-07-15),
15. 7368468 - Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them (2008-05-06),

Title: Unveiling the Innovative Journey of Inventor Tamas Koltai

Introduction:

In the realm of innovation and pharmaceutical advancements, inventor Tamas Koltai has made remarkable contributions that have reshaped the industry. Based in Netanya, IL, Koltai's inventive spirit and dedication have led to the creation of 16 patented technologies, with a focus on crystalline structures and pharmaceutical compositions.

Latest Patents:

Among his recent patents is the groundbreaking "Crystalline solid rasagiline base," which introduces crystalline R(+)-N-propargyl-1-aminoindan and innovative pharmaceutical formulations. Additionally, Koltai has unveiled novel crystalline forms of Nilotinib HCl, paving the way for enhanced drug delivery systems and treatment methodologies.

Career Highlights:

Throughout his career, Tamas Koltai has harnessed his expertise while working at reputable organizations such as Teva Pharmaceutical Industries Limited. His tenure at Teva Pharmaceutical Industries Limited has been marked by a commitment to excellence and a relentless pursuit of cutting-edge solutions in the pharmaceutical sector.

Collaborations:

In his quest for innovation, Koltai has collaborated with esteemed professionals in the field, including coworkers Judith Aronhime and Anton Frenkel. Together, they have synergized their talents to drive forward groundbreaking projects and foster a culture of creativity and exploration.

Conclusion:

In summary, Tamas Koltai stands as a beacon of innovation in the world of pharmaceuticals, with a prolific portfolio of patents and a track record of transformative discoveries. His work continues to inspire and shape the future of the industry, leaving an indelible mark on the landscape of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…